Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ioffe

Showing results (611-620 of 629) with videos related to

Pageof 63
Sort By:
Molecular Cancer Therapeutics|March 8, 2017
Characterization of the Anti-PD-1 Antibody REGN2810 and Its Antitumor Activity in Human <i>PD-1</i> Knock-In MiceElena Burova, Aynur Hermann, Janelle Waite, et al.
International Journal of Cancer|October 25, 2017
Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 StudyA S Felix, T M Brasky, D E Cohn, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 15, 2018
Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade)Naveena Singh, Lynn Hirschowitz, Richard Zaino, et al.
American Journal of Obstetrics and Gynecology|August 11, 2018
Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 StudyAshley S Felix, David E Cohn, Theodore M Brasky, et al.
Journal of the National Cancer Institute|April 5, 2017
Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and RecurrenceTheodore M Brasky, Ashley S Felix, David E Cohn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2014
Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199Mark E Sherman, Marion Piedmonte, Phuong L Mai, et al.
The American Journal of Gastroenterology|August 14, 2024
Validation of an Epigenetic Prognostic Assay to Accurately Risk-Stratify Patients With Barrett EsophagusSarah E Laun, Lisa Kann, Jerome Braun, et al.
The Journal of Clinical Investigation|December 10, 2013
MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosisAtsushi Terunuma, Nagireddy Putluri, Prachi Mishra, et al.
Nature|June 24, 2021
Accurately computing the electronic properties of a quantum ringC Neill, T McCourt, X Mi, et al.
Science (New York, N.Y.)|October 28, 2021
Information scrambling in quantum circuitsXiao Mi, Pedram Roushan, Chris Quintana, et al.
Pageof 63

Showing results (611-620 of 629) with videos related to

Sort By:
Pageof 63
Molecular Cancer Therapeutics|March 8, 2017
Characterization of the Anti-PD-1 Antibody REGN2810 and Its Antitumor Activity in Human <i>PD-1</i> Knock-In MiceElena Burova, Aynur Hermann, Janelle Waite, et al.
International Journal of Cancer|October 25, 2017
Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 StudyA S Felix, T M Brasky, D E Cohn, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 15, 2018
Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade)Naveena Singh, Lynn Hirschowitz, Richard Zaino, et al.
American Journal of Obstetrics and Gynecology|August 11, 2018
Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 StudyAshley S Felix, David E Cohn, Theodore M Brasky, et al.
Journal of the National Cancer Institute|April 5, 2017
Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and RecurrenceTheodore M Brasky, Ashley S Felix, David E Cohn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2014
Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199Mark E Sherman, Marion Piedmonte, Phuong L Mai, et al.
The American Journal of Gastroenterology|August 14, 2024
Validation of an Epigenetic Prognostic Assay to Accurately Risk-Stratify Patients With Barrett EsophagusSarah E Laun, Lisa Kann, Jerome Braun, et al.
The Journal of Clinical Investigation|December 10, 2013
MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosisAtsushi Terunuma, Nagireddy Putluri, Prachi Mishra, et al.
Nature|June 24, 2021
Accurately computing the electronic properties of a quantum ringC Neill, T McCourt, X Mi, et al.
Science (New York, N.Y.)|October 28, 2021
Information scrambling in quantum circuitsXiao Mi, Pedram Roushan, Chris Quintana, et al.
Pageof 63